Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 354.4k | $5.30 | $1.9M | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 92.1k | $1.94 | $178.6k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 55k | $1.04 | $57.2k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Disposition | Stock Option | 210k | $0.96 | $201.6k | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 354.4k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 92.1k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 55k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.00 | $0 | | 10/02/2023 |
10/02/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 70.6k | $0.31 | $21.9k | | 10/02/2023 |
07/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 16.3k | $0.36 | $5.9k | | 07/03/2023 |
02/21/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 210k | $0.96 | $201.6k | | 02/21/2023 |
01/03/2023 | Oncternal Therapeutics, Inc. | GTXI | Payment of Exercise | Common Stock | 10k | $1.02 | $10.2k | | 01/03/2023 |
07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 82.5k | $0.00 | $0 | | 07/28/2022 |
07/28/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 55k | $1.04 | $57.2k | | 07/28/2022 |
01/27/2022 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 10k | $1.69 | $16.9k | | 01/27/2022 |
01/20/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 92.1k | $1.94 | $178.6k | | 01/20/2022 |
01/03/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Common Stock | 57.1k | $0.00 | $0 | | 01/03/2022 |